Metraipolis › archive › dc_7b4aaa0b35e5

Fundamentals and emerging frontiers in p53-targeted drug development — Europe PMC PMID:42306789

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42306789
DOI
10.1016/j.bbrep.2026.102661
License (as archived)
solo-consultazione
Archived
2026-10-31T19:52:58.412Z
SHA-256 of the archived text
375ef89a58e5553d10b6a08e75287b8063e0480990c22f3b439ac3343b94ecf3
Stable URL of this page
https://metraipolis.com/documento/dc_7b4aaa0b35e5

How to cite

Fundamentals and emerging frontiers in p53-targeted drug development — Europe PMC PMID:42306789 — Europe PMC (en), https://europepmc.org/article/MED/42306789 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b4aaa0b35e5 (Metraipolis archive dc_7b4aaa0b35e5, sha256 375ef89a58e5553d10b6a08e75287b8063e0480990c22f3b439ac3343b94ecf3)
BibTeX
@misc{dc7b4aaa0b35e5,
  title = {Fundamentals and emerging frontiers in p53-targeted drug development — Europe PMC PMID:42306789},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42306789},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b4aaa0b35e5; sha256 375ef89a58e5553d10b6a08e75287b8063e0480990c22f3b439ac3343b94ecf3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42306789. Agents can read the archived copy with the MCP tool read_document.